ArticlePloS one2025
Global burden and trends of age-related and other hearing loss: A 32-year analysis and future projections based on the GBD 2021.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Access and Attrition Across Audiology and Cochlear Implant Care Among Older Adults with Bilateral Sensorineural Hearing Loss.Otology & neurotology open · 2026Article
- Sex differences in global burden of Congenital Heart Anomalies in children under five from 1990 to 2021.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate the global, regional, and national burdens of and trends in age-related and other hearing loss (ARoHL) from 1990-2021 based on the Global Burden of Disease 2021 database.
methodsThis study examined trends and disparities in the prevalence and years lived with disability (YLDs) of patients with ARoHL across age, sex, and the sociodemographic index (SDI). The estimated annual percentage change (EAPC) was calculated to assess temporal trends. Decomposition analysis, cross-country inequality analysis, and frontier analysis were employed to reveal additional facets of the ARoHL burden, whereas Bayesian Age-Period-Cohort (BAPC) modeling projected future trends to 2040.
resultsARoHL remains a critical public health challenge. The global age-standardized prevalence rate (ASPR) increased significantly from 1.71 (95% UI: 1.63-1.80) ×10⁴ to 1.81 (95% UI: 1.73-1.89) ×10⁴ per 100,000 (EAPC = 0.163; 95% CI: 0.154-0.172), whereas the age-standardized YLD rate (ASYR) increased from 499.37 to 525.87 per 100,000 (EAPC = 0.171; 95% CI: 0.161-0.180). Decomposition analysis revealed that epidemiological changes contributed 37.28% to the increase in YLDs. Globally and across all five SDI regions without age distinction, the male ASPR and ASYR were consistently greater than the female ASPR and ASYR at all time points. The relationship between the SDI and ARoHL burden is complex. BAPC projections indicate stable ASPRs and ASYRs through 2040 despite increasing cases and YLDs.
conclusionsThe global ASPR of ARoHL increased by 5.63% and that of ASYR increased by 5.31% from 1990-2021, with the number of cases and YLDs doubling. Targeted interventions and policies must address this growing public health challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.